Systemic Administration of FC-77 Dampens Ischemia–Reperfusion-Induced Acute Lung Injury in Rats
- 186 Downloads
Systemic administration of perfluorocarbons (PFCs) reportedly attenuates acute lung injury induced by acid aspiration and phorbol myristate acetate. However, the effects of PFCs on ischemia–reperfusion (IR)-induced lung injury have not been investigated. Typical acute lung injury was induced in rats by 60 min of ischemia and 60 min of reperfusion in isolated and perfused rat lung model. Rat lungs were randomly assigned to receive PBS (control), 1 % FC-77, IR only, or IR with different doses of FC-77 (0.1 %, 0.5 %, or 1 %). Subsequently, bronchoalveolar lavage fluid (BALF), perfusate, and lung tissues were collected to evaluate the degree of lung injury. IR caused a significant increase in the following parameters: pulmonary arterial pressure, capillary filtration coefficient, lung weight gain, lung weight/body weight ratio, wet/dry lung weight ratio, and protein concentration in BALF. TNF-α and cytokine-induced neutrophil chemoattractant-1 concentrations in perfusate samples and MDA concentration and MPO activities in lung tissues were also significantly increased. Histopathology showed increased septal thickness and neutrophil infiltration in the lung tissues. Furthermore, NF-κB activity was significantly increased in the lungs. However, pretreatment with 1 % FC-77 prior to IR significantly attenuated the increases in these parameters. In conclusion, our results suggest that systemic FC-77 administration had a protective effect on IR-induced acute lung injury. These protective mechanisms may have been mediated by the inhibition of NF-κB activation and attenuation of subsequent inflammatory response.
KEY WORDSischemia–reperfusion acute lung injury perfluorocarbon FC-77
This study was supported, in part, by NSC 98-2314-B-016-034-MY2 from the National Science Council of Taiwan; MAB101-63 from the Ministry of National Defense; grants 10132, 1032, and 10137 from Taoyuan Armed Forces General Hospital; and TSGH-102-066 from Tri-Service General Hospital, Taiwan.
- 2.Hirschl, R.B., T. Pranikoff, C. Wise, M.C. Overbeck, P. Gauger, R.J. Schreiner, R. Dechert, and R.H. Bartlett. 1996. Initial experience with partial liquid ventilation in adult patients with the acute respiratory distress syndrome. JAMA: The Journal of the American Medical Association 275: 383–389.CrossRefGoogle Scholar
- 3.Papo, M.C., P.R. Paczan, B.P. Fuhrman, D.M. Steinhorn, L.J. Hernan, C.L. Leach, B.A. Holm, J.E. Fisher, and B.A. Kahn. 1996. Perfluorocarbon-associated gas exchange improves oxygenation, lung mechanics, and survival in a model of adult respiratory distress syndrome. Critical Care Medicine 24: 466–474.PubMedCrossRefGoogle Scholar
- 5.Hirschl, R.B., M. Croce, D. Gore, H. Wiedemann, K. Davis, J. Zwischenberger, and R.H. Bartlett. 2002. Prospective, randomized, controlled pilot study of partial liquid ventilation in adult acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine 165: 781–787.PubMedCrossRefGoogle Scholar
- 14.Maevsky, E., G. Ivanitsky, L. Bogdanova, O. Axenova, N. Karmen, E. Zhiburt, R. Senina, S. Pushkin, I. Maslennikov, A. Orlov, and I. Marinicheva. 2005. Clinical results of Perftoran application: present and future. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology 33: 37–46.PubMedCrossRefGoogle Scholar
- 37.Ross, S.D., I.L. Kron, J.J. Gangemi, K.S. Shockey, M. Stoler, J.A. Kern, C.G. Tribble, and V.E. Laubach. 2000. Attenuation of lung reperfusion injury after transplantation using an inhibitor of nuclear factor-kappaB. American Journal of Physiology. Lung Cellular and Molecular Physiology 279: L528–L536.PubMedGoogle Scholar
- 38.Haeberle, H.A., F. Nesti, H.J. Dieterich, Z. Gatalica, and R.P. Garofalo. 2002. Perflubron reduces lung inflammation in respiratory syncytial virus infection by inhibiting chemokine expression and nuclear factor-kappa B activation. American Journal of Respiratory and Critical Care Medicine 165: 1433–1438.PubMedCrossRefGoogle Scholar
- 40.Haufe, D., T. Luther, M. Kotzsch, L. Knels, and T. Koch. 2004. Perfluorocarbon attenuates response of concanavalin A-stimulated mononuclear blood cells without altering ligand–receptor interaction. American Journal of Physiology. Lung Cellular and Molecular Physiology 287: L210–L216.PubMedCrossRefGoogle Scholar